"MAC Clinical Research is a healthcare organisation dedicated to the development of new and improved treatments through clinical trials."

During the past decade, MAC Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MAC Clinical Research" #1 sponsor was "Allergan" with 3 trials, followed by "Anavex Life Sciences Corp." with 2 trials sponsored, "Evelo Biosciences, Inc." with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MAC Clinical Research" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Anavex Canada Ltd." with 1 trials as a collaborator and "Centessa Pharmaceuticals plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "MAC Clinical Research" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "MAC Clinical Research" in a lesser frequency.

Most popular intervention types in "MAC Clinical Research" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Relamorelin" (3 trials), "ANAVEX2-73" (1 trials), "AVP-786" (1 trials) and "EDP1815" (1 trials). Other intervention names were less common.

The vast majority of trials in "MAC Clinical Research" are 15 trials for "All" genders.

Currently, there are NaN active trials in "MAC Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in MAC Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in MAC Clinical Research, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

MAC Clinical Research has several departments that took part in Clinical trials: "MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence" - 3 trials